Your browser doesn't support javascript.
loading
Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial.
Barco, Stefano; Voci, Davide; Held, Ulrike; Sebastian, Tim; Bingisser, Roland; Colucci, Giuseppe; Duerschmied, Daniel; Frenk, André; Gerber, Bernhard; Götschi, Andrea; Konstantinides, Stavros V; Mach, François; Robert-Ebadi, Helia; Rosemann, Thomas; Simon, Noemi R; Spechbach, Hervé; Spirk, David; Stortecky, Stefan; Vaisnora, Lukas; Righini, Marc; Kucher, Nils.
Affiliation
  • Barco S; Department of Angiology, University Hospital Zurich, Zurich, Switzerland; Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany. Electronic address: stefano.barco@usz.ch.
  • Voci D; Department of Angiology, University Hospital Zurich, Zurich, Switzerland.
  • Held U; Department of Biostatistics at Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
  • Sebastian T; Department of Angiology, University Hospital Zurich, Zurich, Switzerland.
  • Bingisser R; Emergency Department, University Hospital Basel, Basel, Switzerland.
  • Colucci G; Service of Hematology, Clinica Luganese Moncucco, Lugano, Switzerland; Department of Hematology, University of Basel, Basel, Switzerland; Clinica Sant'Anna, Sorengo, Switzerland.
  • Duerschmied D; Department of Cardiology, Angiology, Haemostaseology and Medical Intensive Care, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University, Germany; European Center for AngioScience (ECAS) and German Center for Cardiovascular Research (DZHK) partner site Heidelberg-Mannheim
  • Frenk A; Department of Cardiology, University Hospital of Bern, University of Bern, Bern, Switzerland.
  • Gerber B; Clinic of Hematology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland; University of Zurich, Zurich, Switzerland.
  • Götschi A; Department of Biostatistics at Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
  • Konstantinides SV; Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany; Department of Cardiology, Democritus University of Thrace, Komotini, Greece.
  • Mach F; Cardiology Division, Geneva University Hospitals, Geneva, Switzerland.
  • Robert-Ebadi H; Division of Angiology and Hemostasis, Department of Medicine, Geneva University Hospitals, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Switzerland.
  • Rosemann T; Institute of Primary Care, Zurich, Switzerland.
  • Simon NR; Emergency Department, University Hospital Basel, Basel, Switzerland.
  • Spechbach H; Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland.
  • Spirk D; Institute of Pharmacology, University of Bern, Bern, Switzerland.
  • Stortecky S; Department of Cardiology, University Hospital of Bern, University of Bern, Bern, Switzerland.
  • Vaisnora L; Department of Cardiology, University Hospital of Bern, University of Bern, Bern, Switzerland.
  • Righini M; Division of Angiology and Hemostasis, Department of Medicine, Geneva University Hospitals, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Switzerland.
  • Kucher N; Department of Angiology, University Hospital Zurich, Zurich, Switzerland; University of Zurich, Zurich, Switzerland.
Lancet Haematol ; 9(8): e585-e593, 2022 Aug.
Article in En | MEDLINE | ID: mdl-35779558
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombosis / Enoxaparin / COVID-19 Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Lancet Haematol Year: 2022 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombosis / Enoxaparin / COVID-19 Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Lancet Haematol Year: 2022 Document type: Article